About HotSpot Therapeutics
HotSpot Therapeutics is a company based in Boston (United States) founded in 2017.. HotSpot Therapeutics has raised $210 million across 3 funding rounds from investors including Atlas Venture, Revelation Partners and Life Sciences Partners. The company has 37 employees as of December 31, 2022. HotSpot Therapeutics offers products and services including Smart Allostery™ Platform. HotSpot Therapeutics operates in a competitive market with competitors including Insitro, TOLREMO therapeutics, Certara, Inpharmatica and CytoReason, among others.
- Headquarter Boston, United States
- Employees 37 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hotspot Therapeutics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$210 M (USD)
in 3 rounds
-
Latest Funding Round
$100 M (USD), Series C
Nov 29, 2021
-
Investors
Atlas Venture
& 13 more
-
Employee Count
37
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HotSpot Therapeutics
HotSpot Therapeutics offers a comprehensive portfolio of products and services, including Smart Allostery™ Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates AI, pharmacology, and chemistry for allosteric medicine development.
Unlock access to complete
Unlock access to complete
Funding Insights of HotSpot Therapeutics
HotSpot Therapeutics has successfully raised a total of $210M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $100.0M
-
First Round
First Round
(17 Jul 2018)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - HotSpot Therapeutics | Valuation | Pivotal bioVenture Partners | |
| May, 2020 | Amount | Series B - HotSpot Therapeutics | Valuation | SR One | |
| Jul, 2018 | Amount | Series A - HotSpot Therapeutics | Valuation | Atlas Venture , Sofinnova Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HotSpot Therapeutics
HotSpot Therapeutics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Atlas Venture, Revelation Partners and Life Sciences Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HotSpot Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HotSpot Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hotspot Therapeutics Comparisons
Competitors of HotSpot Therapeutics
HotSpot Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, TOLREMO therapeutics, Certara, Inpharmatica and CytoReason, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hotspot Therapeutics
Frequently Asked Questions about HotSpot Therapeutics
When was HotSpot Therapeutics founded?
HotSpot Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is HotSpot Therapeutics located?
HotSpot Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is HotSpot Therapeutics a funded company?
HotSpot Therapeutics is a funded company, having raised a total of $210M across 3 funding rounds to date. The company's 1st funding round was a Series A of $45M, raised on Jul 17, 2018.
How many employees does HotSpot Therapeutics have?
As of Dec 31, 2022, the latest employee count at HotSpot Therapeutics is 37.
What does HotSpot Therapeutics do?
HotSpot Therapeutics offers a proprietary platform for protein structure-function analysis. The company has developed the proprietary technology platform used to analyze the allosteric druggable sites on the regulatory proteins required for its function using novel compounds.
Who are the top competitors of HotSpot Therapeutics?
HotSpot Therapeutics's top competitors include Insitro, Certara and GRO Biosciences.
What products or services does HotSpot Therapeutics offer?
HotSpot Therapeutics offers Smart Allostery™ Platform.
Who are HotSpot Therapeutics's investors?
HotSpot Therapeutics has 14 investors. Key investors include Atlas Venture, Revelation Partners, Life Sciences Partners, Tekla Capital Management, and Monashee Investment Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.